| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.058 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |